Everything below concerns LC-MS/MS. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-10-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine in major jurisdictions | Sold as a research chemical; legal status varies |
| Anti-doping status | Prohibited by the World Anti-Doping Agency | Listed under non-approved substances or related category |
| Typical analytical method | LC-MS/MS | Used for detection and confirmation in biological samples |
| Storage temperature | −20 °C or lower for solid | Desiccated and protected from light |
| Common solution solvents | DMSO; ethanol | Aqueous solubility is limited |
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
A member of parliament refers to the elected members of the federal Bundestag at the Reichstag building in Berlin. In German a member is called Mitglied des Bundestages (member of the Federal Diet) or officially Mitglied des Deutschen Bundestages (member of the German Federal Diet), abbreviated MdB and attached . Unofficially the term Abgeordneter (lit. 'delegate', i.e. of a certain electorate) is also common (abbreviated Abg., never follows the name but precedes it). In accordance with article 38 of the Basic Law for the Federal Republic of Germany, which is the German constitution, "[m]embers of the German Bundestag shall be elected in general, direct, free, equal, and secret elections. They shall be representatives of the whole people, not bound by orders or instructions, and responsible only to their conscience." An important though not constitutionally required feature of German parliamentarianism is a slightly modified proportional representation. The 16 federal states of Germany (Länder) are represented by the Bundesrat at the former Prussian House of Lords, whose members are representatives of the respective Länder's governments and not directly elected by the people.
=== Naming === The etymology of the current name is rooted in its appearance and habitat. Xanthoria derives from the Greek xănthós, meaning 'yellow', with the generic suffix oria ("pertaining to"), and alludes to the lichen's bright orange-yellow color. The species epithet parietina comes from Latin parietina ('of walls'), referring to its frequent occurrence on walls. Thus, the name Xanthoria parietina essentially means "yellow wall (lichen)", a fitting description of this common orange lichen, and one of its several English common names. Other common names used for this species include "common orange lichen", "yellow scales", "maritime sunburst lichen", "wall lichen", and "shore lichen".
Chattopadhyay, R., & Roy, S.* (2002) J Biol Chem, 277, 33641-7. https://doi.org/10.1074/jbc.M203197200 Effect of phosphorylation on the structure and fold of transactivation domain of p53. Kar S., Sakaguchi, K., Shimohigashi, Y., Samaddar, S., Banerjee, R., Basu, G., Swaminathan, V., Kundu, TK., & Roy, S.* (2002) J Biol Chem, 277, 15579-85. https://doi.org/10.1074/jbc.M106915200 Effect of osmolytes and chaperone-like action of P-protein on folding of nucleocapsid protein of Chandipura virus. Majumder A, Basak S, Raha T, Chowdhury SP, Chattopadhyay D, Roy S.* (2001) J Biol Chem. 276, 30948-55.https://doi.org/10.1074/jbc.M011705200 A "master" in base unpairing during isomerization of a promoter upon RNA polymerase binding. Lim, HM., Lee, HJ., Roy, S., & Adhya, S. (2001) Proc Natl Acad Sci (U S A), 98, 14849-52. https://doi.org/10.1073/pnas.261517398 Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. Sakaguchi, K., Saito, S., Higashimoto, Y., Roy, S., Anderson, CW., & Appella, E. (2000) J Biol Chem, 275, 9278-83. https://doi.org/10.1074/jbc.275.13.9278 Interaction of Gal repressor with inducer and operator: induction of gal transcription from repressor-bound DNA. Chatterjee, S., Zhou, YN., Roy, S., & Adhya, S. (1997) Proc Natl Acad Sci (USA), 94 2957-2962. https://doi.org/10.1073/pnas.94.7.2957 A fluorescence anisotropy study of tetramer-dimer equilibrium of l-repressor and its implications for function.
Sources: en.wikipedia.org
== Function == Histatins are antimicrobial and antifungal proteins, and have been found to play a role in wound-closure. A significant source of histatins is found in the serous fluid secreted by Ebner's glands, salivary glands at the back of the tongue, and produced by acinus cells. Here they offer some early defense against incoming microbes. The three major histatins are 1, 3, and 5, which contains 38, 32, and 24 amino acids, respectively. Histatin 2 is a degradation product of histatin 1, and all other histatins are degradation products of Histatin 3 through the process of post-translational proteolysis of the HTN3 gene product. Therefore there are only two genes, HTN1 and HTN3. The N-terminus of histatin 5 allows it to bind with metals, and this can result in the production of reactive oxygen species. Histatins disrupt the fungal plasma membrane, resulting in release of the intracellular content of the fungal cell. They also inhibit the growth of yeast, by binding to the potassium transporter and facilitating in the loss of azole-resistant species. The antifungal properties of histatins have been seen with fungi such as Candida glabrata, Candida krusei, Saccharomyces cerevisiae, and Cryptococcus neoformans. Histatins also precipitate tannins from solution, thus preventing alimentary adsorption. Histatins are a family of small, histidine-rich, cationic peptides found in human saliva. They are part of the innate immune system and play critical roles in oral health, including antifungal activity, wound healing, and cell migration.
The concomitant use of elagolix with medications that inhibit OATP1B1 may increase elagolix levels, and the use of elagolix with strong OATP1B1 inhibitors like ciclosporin and gemfibrozil, which may markedly increase elagolix exposure, is contraindicated. Elagolix is a weak to moderate inducer of CYP3A, and may decrease levels of medications that are substrates of CYP3A4. In addition, elagolix is an inhibitor of P-glycoprotein, and may increase levels of medications that are substrates of P-glycoprotein, such as digoxin. Elagolix has been found to increase exposure to digoxin and ethinylestradiol, whereas it has been found to decrease exposure to rosuvastatin, midazolam, norethisterone, norelgestromin, and norgestrel. Because combined birth control pills and other forms of combined birth control contain an estrogen, and because elagolix treats endometriosis by decreasing estrogen levels in the endometrium, these form of hormonal birth control are likely and expected to decrease the effectiveness of elagolix in the treatment of this condition. The effect of progestogen-only birth control on the effectiveness of elagolix in endometriosis is unknown. However, progestogens are antiestrogenic in the uterus, and high-dose progestin therapy is known to be effective in the treatment of endometriosis similarly to GnRH antagonists. On the basis of limited clinical research, combined birth control pills have also been found to be effective in the treatment of endometriosis, but are likely not as effective as GnRH modulator monotherapy.
== Example secreted proteins == α-Amylase (1A, 1B, 1C) – breaks down carbohydrates, especially starch. Histatin (HTN1, HTN3) – have a variety of roles from inhibiting fungus growth, acting as precursors for enamel, and promoting wound healing. Lactoperoxidase – reacts with thiocyanate ions to produce antimicrobial molecules. Lactoferrin – binds to iron which has antimicrobial effects. Proline rich proteins Basic (1, 2, 3, 4) Acidic (1, 2) Proline-rich protein 4 (PRR4) – Also produced by lacrimal acinar cells Statherin – helps stabilize saliva and prevent calcium precipitation.
== Etymology and regional names == The name "bilberry" appears to have a Scandinavian origin, possibly from as early as 1577, while the earliest known English use of the name "blueberry" dates back to 1594, appearing in the Acts of Parliament of Scotland. The name "bilberry" is similar to the Danish word bølle for whortleberry with the addition of "berry". In Scandinavian languages, terms for bilberries have names with the meaning "blueberry", such as blåbär in Swedish and blåbær in Danish and Norwegian. The bilberry (especially Vaccinium myrtillus) may be called blaeberry in Scottish and Northern English regional dialects, whortleberry in southern England, and fraochán in Ireland.
Sources: en.wikipedia.org
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.
Laboratories typically use LC-MS/MS to detect SR9009 and related compounds in urine or blood. The method is sensitive but depends on sample collection timing. Confirmatory analysis follows quality-control procedures.
Solid material is generally kept cold, dry, and protected from light. Solutions are often stored in sealed containers at low temperature. Stability beyond recommended periods is not well documented.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.